Mother to child transmission of HIV-another complication of bacterial vaginosis?

Journal of Acquired Immune Deficiency Syndromes

Volumn 60, Issue 3, 2012, Pages 221-224

  Watts, D Heather ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; METRONIDAZOLE; MICROBICIDE;

CHLAMYDIA TRACHOMATIS; CHORIOAMNIONITIS; DISEASE TRANSMISSION; FEMALE; FEMALE GENITAL TRACT INFECTION; FETUS; GARDNERELLA INFECTION; GARDNERELLA VAGINALIS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEPTOTRICHIA; MEGASPHAERA; MOBILUNCUS; MYCOPLASMA; MYCOPLASMA HOMINIS; NEISSERIA GONORRHOEAE; NONHUMAN; PELVIC INFLAMMATORY DISEASE; PLACENTAL TRANSFER; PORPHYROMONAS; POSTOPERATIVE INFECTION; PREVOTELLA; PRIORITY JOURNAL; REVIEW; VAGINITIS;

FEMALE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; METAGENOME; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VAGINA;

EID: 84864291880     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318256941c     Document Type: Review

References (46)

1. Atashili J, Poole C, Ndumbe PM, et al. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS. 2008;22:1493-1501.
2. Cu-Uvin S, Hogan JW, Caliendo AM, Et al; For the HIV Epidemiology Research Study. Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis. 2001;33:894-896.
3. Cherpes TL, Meyn LA, Krohn MA, et al. Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis. 2003;37:319-325.
4. Gillet E, Meys JFA, Verstraelen H, et al. Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis. BMC Infect Dis. 2011;11:10-18.
5. Wiesenfeld HC, Hillier SL, Krohn MA, et al. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis. 2003;36:663-668.
6. Wiesenfeld H, Hillier S, Krohn M, et al. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol. 2002;100:456-463.
7. Soper DE, Bump RC, Hurt WG. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am J Obstet Gynecol. 1990;163:1016-1021.
8. Larsson PG, Platz-Christensen JJ, Thejls H, et al. Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: a double-blind, randomized study. Am J Obstet Gynecol. 1992;166:100-103.
9. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med. 1995;333:1737-1742.
10. Goldenberg RL, Thom E, Moawad AH, et al. The preterm prediction study: fetal fibronectin, bacterial vaginosis, and peripartum infection. NICHD Maternal Fetal Medicine Units Network. Obstet Gynecol. 1996;87:656-660.
11. Donders GG, Van Calsteren KV, Bellen G, et al. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG. 2009;116: 1315-1324.
12. Hillier SL, Martius J, Krohn M, et al. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med. 1988;319:972-978.
13. Watts DH, Krohn MA, Hillier SL, et al. Bacterial vaginosis as a risk factor for post-cesarean endometritis. Obstet Gynecol. 1990;75: 52-58.
14. Hillier SL, Krohn MA, Nugent RP, et al. Characteristics of three vaginal flora patterns assessed by gram stain among pregnant women. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol. 1992; 166:938-944.
15. Spiegel CA. Bacterial vaginosis. Rev Med Microbiol. 2002;13: 43-51.
16. Amsel R, Totten PA, Speigel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983; 74:14-22.
17. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29:297-301.
18. Marrazzo JM, Martin DH, Watts DH, et al. Bacterial vaginosis: identifying research gaps, proceedings of a workshop sponsored by DHHS/NIH/NIAID November 19-20, 2008. Sex Transm Dis. 2010;37: 732-744.
19. Fredericks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005;353: 1899-1911.
20. Fredricks DN, Fiedler TL, Thomas KK, et al. Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR. J Clin Microbiol. 2009;47: 721-726.
21. Cherpes TL, Marrazzo JM, Cosentino LA, et al. Hormonal contraceptive use modulates the local inflammatory response to bacterial vaginosis. Sex Transm Infect. 2008;84:57-61.
22. Hedges SR, Barrientes F, Desmond RA, et al. Local and systemic cytokine levels in relation to changes in vaginal flora. J Infect Dis. 2006;193: 556-562.
23. Ma J, Chen T, Mandelin J, et al. Regulation of macrophage activation. Cell Mol Life Sci. 2003;60:2334-2346.
24. Thurman AR, Doncel GF. Innate immunity and inflammatory response to Trichomonas vaginalis and bacterial vaginosis: relationship to HIV acquisition. Am J Reprod Immunol. 2011;65:89-98.
25. Cauci S, Guaschino S, De Aloysio D, et al. Interrelationships of interleukin-8 with interleukin-1beta and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women. Mol Hum Reprod. 2003;9: 53-58.
26. Al-Harthi L, Roebuck KA, Olinger GG, et al. Bacterial vaginosisassociated microflora isolated from the female genital tract activates HIV-1 expression. J Acquir Immune Defic Syndr. 1999;21: 194-202.
27. Baeten JM. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med. 2011;3:77ra29.
28. Taha TE, Gray RH. Genital tract infections and perinatal transmission of HIV. Ann N Y Acad Sci. 2000;918:84-98.
29. Farquhar C, Mbori-Ngacha D, Overbaugh J, et al. Illness during pregnancy and bacterial vaginosis are associated with in-utero HIV-1 transmission. AIDS. 2010;24:153-157.
30. Frank D, Manigart O, Leroy V, et al. Altered vaginal microbiota are associated with perinatal mother-to-child HIV transmission in African women from Burkina Faso. J Acquir Immune Defic Syndr. 2011.
31. Muglia LJ, Katz M. The enigma of spontaneous preterm birth. N Engl J Med. 2010;362:529-535.
32. Consensus workshop. Maternal factors involved in mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr. 1992;5: 1019-1029.
33. Goedert J, Mendez H, Drummond JE, et al. Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-GP 120. Lancet. 1989;2:1351-1354.
34. St Louis M, Kemenga M, Brown C, et al. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. JAMA. 1993;269:2853-2859.
35. Wabire-Mangen F, Gray RH, Mmiro FA, et al. Placental membrane inflammation and risks of maternal-to-infant transmission of HIV-1 in Uganda. J Acquir Immune Defic Syndr. 1999;22:379-385.
36. Chi BH, Mudenda V, Levy J, et al. Acute and chronic chorioamnionitis and the risk of perinatal human immunodeficiency virus-1 transmission. Am J Obstet Gynecol. 2006;194:174-181.
37. Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet. 2008;371:75-84.
38. Gibbs RS, Romero R, Hillier SL, et al. A review of premature birth and subclinical infection. Am J Obstet Gynecol. 1992;166:1515-1528.
39. Jones NM, Holzman C, Friderici KH, et al. Interplay of cytokine polymorphisms and bacterial vaginosis in the etiology of preterm delivery. J Reprod Immunol. 2010;87:82-89.
40. Taha TE, Brown ER, Hoffman IF, et al; and The HPTN 024 Team. A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission. AIDS. 2006;20:1313-1321.
41. Berkeley JS, Fogiel PC, Kindley AD, et al. Peripartum HIV seroconversion: a cautionary tale. Lancet. 1991;340:58-59.
42. Embree JE, Njenga S, Datta P, et al. Risk factors for postnatal motherchild transmission of HIV-1. AIDS. 2000;14:2535-2541.
43. Hayes R, Watson-Jones D, Celum C, et al. Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning? AIDS. 2010;24:S15-S26.
44. Nygren P, Fu R, Freeman M, et al. Screening and treatment for bacterial vaginosis in pregnancy: systematic review to update the 2001 US Preventive Services Task Force Recommendation. Report No: 08-05106-EF-1. Agency for Healthcare Research and Quality (US); 2008 January.
45. Lamont RF, Nhan-Chang C-L, Sobel JD, et al. Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol. 2011;205:177-190.
46. British HIV Association. Guidelines for the management of HIV infection in pregnant women 2012. Available at: http://www.bhiva.org/documents/- Guidelines/Pregnancy/Pregnancy-Guidelines-for-Consultation120125.pdf. Accessed March 12, 2012.